Publications by authors named "S Fisker"
Article Synopsis
- - The VAM-IHCA trial aimed to evaluate the long-term effects of vasopressin and methylprednisolone on adult patients who experienced in-hospital cardiac arrest after receiving epinephrine.
- - The study included 501 patients and found no significant difference in survival rates or favorable neurological outcomes at 1 year between the treatment group and the placebo group.
- - Results indicated that administering vasopressin and methylprednisolone did not enhance long-term survival or quality of life for patients compared to placebo.
Importance: Previous trials have suggested that vasopressin and methylprednisolone administered during in-hospital cardiac arrest might improve outcomes.
Objective: To determine whether the combination of vasopressin and methylprednisolone administered during in-hospital cardiac arrest improves return of spontaneous circulation.
Design, Setting, And Participants: Multicenter, randomized, double-blind, placebo-controlled trial conducted at 10 hospitals in Denmark.
Objective: Senescent changes in body composition and muscle strength are accompanied by reduced production of GH and IGF1, but the causal relationship remains elusive. We speculate that serum bioactive IGF1, measured by the IGF1 kinase receptor activation assay, is closer related to human physiological ageing than total IGF1 measured by immunoassay.
Design: We conducted a cross-sectional study in 150 adult males and females, between 20 and 70 years.
Objective: To investigate whether pegvisomant treatment in acromegaly induces gradual elevations in endogenous serum growth hormone (GH) levels and whether serum pegvisomant levels predict the therapeutic outcome.
Patients And Methods: Seventeen patients (6 women), mean age 46·3 years (range: 23·2-76·2), were studied. For each patient, four hospital visits were identified including 'active disease' (no treatment) and last follow-up.